This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Obesity and cancer risk

Authoring team

  • obesity has been associated with increased risk for a number of different types of cancer:
    • evidence has been most consistent for endometrial cancer, breast cancer in postmenopausal women, and renal cell cancer
    • there have also been associations reported regarding obesity and colorectal, prostate and pancreatic cancer
    • it has been estimated that obesity is responsible for approximately 40% of endometrial cancers, 25% of renal cancers, and 10% each of colonic and breast cancers in Europe (2)
      • there is also evidence that obesity may promote the development of a more aggressive form of prostate cancer, resulting in higher recurrence rates after primary therapy and higher cancer mortality rates overall (3)
    • suggested mechanisms by which obesity may influence cancer risk include alteration in hormonal patterns, including sex hormones, insulin and insulin-like growth factor-1
      • with respect to endometrial cancer and obesity it has been theorised that the peripheral conversion of androstenedione to oestrone by adipocytes leads to a chronic low-level increase in oestrogen exposure and hence an increased risk of endometrial adenocarcinoma (4)

With respect to obesity and colorectal cancer (CRC) risk (5):

  • central obesity is a much stronger predictor of CRC and may account for most of the CRC risk linked to obesity
  • findings also emphasize the need for incorporating measures such as WHR (waist hip ratio) alongside BMI in clinical practice to improve obesity prevention and management

Reference:

  1. Lipids. 1998 Nov;33(11):1055-9.
  2. Bianchini F et al. Weight control and physical activity in cancer prevention. Obes Rev 3 (2002);. 5–8
  3. Curr Opin Urol. 2005 May;15(3):167-71
  4. Pavelka JC et al. Morbid obesity and endometrial cancer: surgical, clinical, and pathologic outcomes in surgically managed patients.Gynecologic Oncology 2004; 95 (3): 588-592
  5. Safizadeh, F., Mandic, M., Schöttker, B. et al. Central obesity may account for most of the colorectal cancer risk linked to obesity: evidence from the UK Biobank prospective cohort. Int J Obes (2024).

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.